What's in Barrie Urology Associates's pipeline?

Barrie Urology Associates has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Barrie Urology Associates's portfolio?

Top competitors by shared drug class: National Taiwan University Hospital, Pfizer, Albert Einstein College of Medicine, Children's Hospitals and Clinics of Minnesota, Daewon Pharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/barrie-urology-associates.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Barrie Urology Associates — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Barrie Urology Associates pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Solifenacin succinate treatment	Solifenacin succinate treatment	marketed	Muscarinic M3 receptor antagonist	M3 muscarinic acetylcholine receptor	Urology
Oxycodone and acetaminophen combination treatment	Oxycodone and acetaminophen combination treatment	marketed	Opioid analgesic combination	Mu opioid receptor (oxycodone); cyclooxygenase enzymes (acetaminophen)	Pain Management

Therapeutic area mix

Pain Management · 1
Urology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

National Taiwan University Hospital · 2 shared drug classes
Pfizer · 2 shared drug classes
Albert Einstein College of Medicine · 1 shared drug class
Children's Hospitals and Clinics of Minnesota · 1 shared drug class
Daewon Pharmaceutical Co., Ltd. · 1 shared drug class
Henry Ford Health System · 1 shared drug class
Janssen Korea, Ltd., Korea · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Barrie Urology Associates:

Cite this brief

Drug Landscape (2026). Barrie Urology Associates — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/barrie-urology-associates. Accessed 2026-05-17.